Human cell hybrids: analysis of transformation and tumorigenicity. 1982

E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson

Intraspecific human-human cell hybrids provide a stable model system with which to investigate the genetic control of transformed and tumorigenic phenotypes. Using this system it has been shown that these phenotypes are under separate genetic control. Furthermore, the tumorigenic phenotype can be complemented by fusion of different tumorigenic cells, resulting in nontumorigenic hybrids. This system also provides information on the control of differentiated function. Molecular cytogenetic techniques should reveal the nature of the chromosomal control of neoplastic transformation.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein

Related Publications

E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
September 1982, European journal of cancer & clinical oncology,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
January 1979, Somatic cell genetics,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
January 1981, Experimental cell biology,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
January 1990, Progress in clinical and biological research,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
January 1982, Cytogenetics and cell genetics,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
April 1980, Journal of cell science,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
January 1980, Cytogenetics and cell genetics,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
January 1981, Experimental cell biology,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
July 1980, International journal of cancer,
E J Stanbridge, and C J Der, and C J Doersen, and R Y Nishimi, and D M Peehl, and B E Weissman, and J E Wilkinson
September 1983, Journal of the National Cancer Institute,
Copied contents to your clipboard!